The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA, 2002; 287:2563–2569.
HermanidesJ, NørgaardK, BruttomessoD, MathieuC, FridA, DayanCM, DiemP, FermonC, WentholtIM, HoekstraJB, DeVriesJH. Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabet Med, 2011; 28:1158–1167.
4.
BergenstalRM, TamborlaneWV, AhmannA, BuseJB, DaileyG, DavisSN, JoyceC, PeoplesT, PerkinsBA, WelshJB, WilliSM, WoodMA. STAR 3 Study Group: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med, 2010; 363:311–320Erratum in: N Engl J Med 2010;363:1092.
5.
BergenstalRM, KlonoffDC, GargSK, BodeBW, MeredithM, SloverRH, AhmannAJ, WelshJB, LeeSW, KaufmanFR. the ASPIRE In-Home Study Group: Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med, 2013; 369:224–232.
6.
LyTT, NicholasJA, RetterathA, Mun LimE, DavisEA, JonesTW. Reduction of severe hypoglycemia with sensor-augmented insulin pump therapy and automated insulin suspension in patients with type 1 diabetes [abstract]Diabetes, 2013; 62,Suppl 1:A58.
7.
KadishAH. Automation control of blood sugar. I. A servomechanism for glucose monitoring and control. Am J Med Electron, 1964; 3:82–86.
8.
BretonM, FarretA, BruttomessoD, AndersonS, MagniL, PatekS, Dalla ManC, PlaceJ, DemartiniS, Del FaveroS, ToffaninC, Hughes-KarvetskiC, DassauE, ZisserH, DoyleFJ3rd, De NicolaoG, AvogaroA, CobelliC, RenardE, KovatchevB. International Artificial Pancreas Study Group: Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes, 2012; 61:2230–2237.
9.
DassauE, ZisserH, HarveyRA, PercivalMW, GrosmanB, BevierW, AtlasE, MillerS, NimriR, JovanovicL, DoyleFJ3rd. Clinical evaluation of a personalized artificial pancreas. Diabetes Care, 2013; 36:801–809.
10.
TurksoyK, BayrakES, QuinnL, LittlejohnE, CinarA. Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement. Diabetes Technol Ther, 2013; 15:386–400.
11.
Van BonAC, JonkerLD, KoebruggeR, KoopsR, HoekstraJB, DeVriesJH. Feasibility of a bihormonal closed-loop system to control postexercise and postprandial glucose excursions. J Diabetes Sci Technol, 2012; 6:1114–1122.
12.
HaidarA, LegaultL, DallaireM, AlkhateebA, CoriatiA, MessierV, ChengP, MilletteM, BouletB, Rabasa-LhoretR. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. CMAJ, 2013; 185:297–305.
13.
RussellSJ, El-KhatibFH, NathanDM, MagyarKL, JiangJ, DamianoER. Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care, 2012; 35:2148–2155.
14.
ElleriD, AllenJM, BiagioniM, KumareswaranK, LeelarathnaL, CaldwellK, NodaleM, WilinskaME, AceriniCL, DungerDB, HovorkaR. Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes. Pediatr Diabetes, 2012; 13:449–453.
15.
JacobsPG, El YoussefJ, CastleJR, EngleJM, BraniganDL, JohnsonP, MassoudR, KamathA, WardWK. Development of a fully automated closed loop artificial pancreas control system with dual pump delivery of insulin and glucagon. Conf Proc IEEE Eng Med Biol Soc, 2011; 2011:397–400.
16.
PhillipM, BattelinoT, AtlasE, KordonouriO, BratinaN, MillerS, BiesterT, StefanijaMA, MullerI, NimriR, DanneT. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med, 2013; 368:824–833.
17.
KovatchevBP, RenardE, CobelliC, ZisserHC, Keith-HynesP, AndersonSM, BrownSA, ChernavvskyDR, BretonMD, FarretA, PelletierMJ, PlaceJ, BruttomessoD, Del FaveroS, VisentinR, FilippiA, ScottonR, AvogaroA, DoyleFJ3rd. Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care, 2013; 36:1851–1858.
18.
van BonA, LuijfYM, KoebruggeR, KoopsR, HoekstraJBL, DeVriesJH. Feasibility of a portable bihormonal closed-loop system to control glucose excursions at home for 48 hours [abstract]Diabetes Technol Ther, 2013; 15,Suppl 1:A–24.
19.
van BonAC, BrouwerTB, von BasumG, HoekstraJB, DeVriesJH. Future acceptance of an artificial pancreas in adults with type 1 diabetes. Diabetes Technol Ther, 2011; 13:731–736.
20.
SchoemakerM. A novel needle type sensor [abstract]Diabetes Technol Ther, 2013; 15,Suppl 1:A–21.
21.
El-KhatibFH, RussellSJ, NathanDM, SutherlinRG, DamianoER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med, 2010; 2:27ra27.
22.
CastleJR, EngleJM, El YoussefJ, MassoudRG, YuenKC, KaganR, WardWK. Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care, 2010; 33:1282–1287.
23.
Medtronic Diabetes: Overnight closed loop study in U.S.http://clinicaltrials.gov/ct2/show/NCT01857973. 2013 July 12.
